Bridgemedica and Alcresta Therapeutics Honored as Gold Winners in the 2016 Medical Design Excellence Award (MDEA)

MANSFIELD, Mass.–(BUSINESS WIRE)– Bridgemedica
today announced that RELiZORB™ has been selected as the Gold Winner
in the Over-the-Counter and Self-Care category of the
18th Annual Medical Design Excellence Awards competition. The 2016 MDEA
winning products were announced at the 2016 MDEA Ceremony held Tuesday,
June 14, 2016 in conjunction with the MD&M East event at the Jacob K.
Javits Convention Center in New York.

RELiZORB™ is a digestive enzyme cartridge designed to
mimic the function of
pancreatic lipase by hydrolyzing fats
in enteral tube feed formula just prior to
ingestion in
order to increase absorbable calories and reduce fatty acid
deficiencies
of critical fats.

“We are honored to be recognized by the MDEA judges for the design
of this innovative product,” said Bob Pelletier, President of Bridgemedica,
“and proud to be a true partner to our client Alcresta
Therapeutics« 

The MDEA
are the medtech industry’s premier design competition committed to
searching worldwide for the highest caliber finished medical devices,
products, systems, or packaging available on the market. The awards
program celebrates the achievements of the medical device manufacturers,
their suppliers, and the many people behind the scenes—engineers,
scientists, designers, and clinicians—who are responsible for the
cutting-edge products that are saving lives; improving patient
healthcare; and transforming medtech—one innovation at a time. For more
information about the Medical Design Excellence Awards visit the MDEA
website at www.MDEAwards.com.

About
Bridgemedica is a turnkey concept-to-supply partner providing a
single source solution to medical device and biotech companies lacking
engineering resources, technical expertise or operational infrastructure
to move their new product ideas or project(s) to completion rapidly.

Service offerings includes industrial design, product design, product &
process development, packaging design, sourcing, assembly/manufacturing,
and packaging services emphasizing critical milestone realization, speed
to market and earlier product revenue generation. In addition,
Bridgemedica offers services in the areas of design control, compliance
related documentation tracking, and regulatory filings. Bridgemedica
also has the unique capability of developing and assembling Combination
Products which brings together a medical device with a Drug or Biologic.

The company is ISO 13485:2003 registered an FDA registered. Bridgemedica
has 41,000 square feet of space including an ISO Class 8 Certified
Cleanroom (100,000). The facility includes offices, five development
labs (including mechanical, electrical, process and wet lab), a QA lab,
a rapid prototyping shop including 3D printing, collaboration space,
clean room assembly, electro-mechanical assembly and warehouse.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160801005252/en/